Teva, Viatris win new chance to challenge J&J schizophrenia drug patent ...Middle East

Devdiscourse - Opinion
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their challenges to a patent covering a blockbuster Johnson & Johnson schizophrenia drug, giving them a new chance to clear a path to launch cheaper generic versions of the medicine.

Hence then, the article about teva viatris win new chance to challenge j j schizophrenia drug patent was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Teva, Viatris win new chance to challenge J&J schizophrenia drug patent )

Apple Storegoogle play

Last updated :

Also on site :